MFDS — authorised 16 October 2007
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Status: likely_approved
🇰🇷 Ixempra Kit in South Korea
MFDS authorised Ixempra Kit on 16 October 2007
Marketing authorisation
Ixempra Kit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Ixempra Kit approved in South Korea?
Yes. MFDS authorised it on 16 October 2007.
Who is the marketing authorisation holder for Ixempra Kit in South Korea?
BRISTOL MYERS SQUIBB holds the South Korean marketing authorisation.